BridgeBio Pharma to Participate in June Investor Events

Rhea-AI Summary

BridgeBio Pharma, Inc. (Nasdaq: BBIO) announced participation in two key investor conferences. The Jefferies Healthcare Conference is scheduled for June 9 at 4:00 pm ET, followed by the Goldman Sachs Global Healthcare Conference on June 15 at 5:00 pm ET.

Live webcasts will be available on the BridgeBio Investors page. A replay will be accessible for 90 days post-event. Founded in 2015, BridgeBio focuses on developing transformative medicines targeting genetic diseases and cancers.

PALO ALTO, Calif., June 06, 2022 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that members of the management team will participate in the following upcoming investor conferences:

• Jefferies Healthcare Conference, New York, NY: Thursday, June 9^th at 4:00 pm ET
• Goldman Sachs Global Healthcare Conference, Ranchos Palos Verdes, CA: Wednesday, June 15^th at 5:00 pm ET

To access the live webcast of BridgeBio’s presentations, please visit the “Events” page within the Investors section of the BridgeBio website at http://investor.bridgebio.com. A replay of the webcasts will be available on the BridgeBio website for 90 days following the event.

About BridgeBio Pharma, Inc.
BridgeBio Pharma, Inc. (BridgeBio) is a commercial-stage biopharmaceutical company founded to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. BridgeBio’s pipeline of development programs ranges from early science to advanced clinical trials. BridgeBio was founded in 2015 and its team of experienced drug discoverers, developers and innovators are committed to applying advances in genetic medicine to help patients as quickly as possible. For more information visit bridgebio.com and follow us on LinkedIn and Twitter.

BridgeBio Contact:
Grace Rauh
Grace.rauh@bridgebio.com
(917) 232-5478

FAQ

When is BridgeBio's participation in the Jefferies Healthcare Conference?

BridgeBio will participate in the Jefferies Healthcare Conference on June 9, 2022, at 4:00 pm ET.

When will BridgeBio present at the Goldman Sachs Global Healthcare Conference?

BridgeBio will present at the Goldman Sachs Global Healthcare Conference on June 15, 2022, at 5:00 pm ET.

How can I access BridgeBio's conference webcasts?

Live webcasts of BridgeBio's presentations can be accessed on their Investors page at http://investor.bridgebio.com.

How long will the BridgeBio presentation replays be available?

Replays of the BridgeBio presentations will be available for 90 days after each event.

What is the focus of BridgeBio Pharma, Inc.?

BridgeBio Pharma focuses on developing medicines for genetic diseases and cancers.